Suppr超能文献

与高房室传导阻滞的 NSTEMI 患者中早期与延迟介入策略相关的结局:一项全国性分析。

Outcomes Associated With Early vs. Delayed Invasive Strategy in NSTEMI Complicated by High Degree AV Block: A Nationwide Analysis.

机构信息

Division of Cardiology, Southern Illinois School of Medicine, Springfield, Illinois.

Department of Medical Education, Weiss Memorial Hospital, Chicago, Illinois.

出版信息

Clin Med Res. 2023 Mar;21(1):1-5. doi: 10.3121/cmr.2022.1753.

Abstract

High degree atrioventricular block (HDAVB) is an uncommon complication of non-ST-segment elevation myocardial infarction (NSTEMI) that frequently necessitates pacemaker implantation. This contemporary analysis compares need for pacemaker implantation based on the timing of intervention in acute NSTEMI complicated by HDAVB. We used 2016-2017 National Inpatient Sample database to identify admissions with NSTEMI and HDAVB. Time to coronary intervention from initial admission was used to segregate the admissions into two groups: early invasive strategy (EIS) (<24 hours) and delayed invasive strategy (DIS) (>24 hours). Multivariable linear and logistic regression analysis was performed to compare in-hospital outcomes among the two groups. Out of 949,984 NSTEMI related admissions, coexistent HDAVB was present in 0.7% (n=6725) patients. Amongst those, 55.61% (n=3740) hospitalizations included invasive intervention (EIS=1320, DIS=2420). Patients treated with EIS were younger (69.95 years vs. 72.38 years, <0.05) and had concomitant cardiogenic shock. Contrarily, prevalence of chronic kidney disease, heart failure, and pulmonary hypertension was higher in DIS group. EIS was associated with lower length of stay and total hospitalization cost. In-hospital mortality and pacemaker implantation rates were not significantly different between patients in the EIS and DIS groups. HDAVB is a rare complication of NSTEMI and often associated with right coronary artery disease. The timing of revascularization does not appear to influence the rate of pacemaker placement in NSTEMI complicated by HDAVB. Further studies are needed to assess if early invasive strategy can benefit all patients with NSTEMI and HDAVB.

摘要

高度房室传导阻滞(HDAVB)是急性非 ST 段抬高型心肌梗死(NSTEMI)的罕见并发症,常需植入起搏器。本研究通过对比 HDAVB 合并 NSTEMI 患者的介入时机,分析起搏器植入的必要性。我们利用 2016-2017 年国家住院患者样本数据库,确定了 NSTEMI 合并 HDAVB 的住院患者。根据初次入院至冠状动脉介入治疗的时间,将患者分为两组:早期侵入性策略(EIS)(<24 小时)和延迟侵入性策略(DIS)(>24 小时)。采用多变量线性和逻辑回归分析比较两组患者的住院转归。在 949984 例 NSTEMI 相关住院患者中,同时存在 HDAVB 的患者占 0.7%(n=6725)。其中,55.61%(n=3740)的住院患者接受了侵入性治疗(EIS=1320,DIS=2420)。EIS 组患者年龄更小(69.95 岁 vs. 72.38 岁,<0.05),且合并心源性休克。相反,DIS 组患者慢性肾脏病、心力衰竭和肺动脉高压的发生率更高。EIS 与较短的住院时间和总住院费用相关。EIS 组和 DIS 组患者的院内死亡率和起搏器植入率无显著差异。HDAVB 是 NSTEMI 的罕见并发症,常与右冠状动脉疾病有关。再灌注治疗时机似乎并不影响 HDAVB 合并 NSTEMI 患者起搏器的植入率。需要进一步研究以评估早期侵入性策略是否能使所有 HDAVB 合并 NSTEMI 患者受益。

相似文献

4
Outcomes in non-ST-segment elevation myocardial infarction complicated by in-hospital cardiac arrest based on management strategy.
Indian Heart J. 2023 Nov-Dec;75(6):443-450. doi: 10.1016/j.ihj.2023.10.004. Epub 2023 Oct 18.
9
Outcomes of Acute Myocardial Infarction in Patients with Rheumatoid Arthritis.
Am J Med. 2020 Oct;133(10):1168-1179.e4. doi: 10.1016/j.amjmed.2020.02.039. Epub 2020 Apr 10.

引用本文的文献

1
Disentangling the phenotypic patterns of hypertension and chronic hypotension.
J Biomed Inform. 2024 Nov;159:104743. doi: 10.1016/j.jbi.2024.104743. Epub 2024 Oct 31.

本文引用的文献

7
ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary.
Heart Rhythm. 2008 Jun;5(6):934-55. doi: 10.1016/j.hrthm.2008.04.015. Epub 2008 May 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验